Search

You searched for "inflammation"

2228 results found

My Top Five: Innovative approaches to dry AMD

2 February 2024 | | EYE - General
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...

Launch of the Routine Health Information Systems – Sensory Functions toolkit

9 August 2023 | WHO, WHO Vision and Eye Care, Routine Health Information Systems, toolkit
This toolkit includes a DHIS2 Sensory functions: eye and ear care digital package and a Guidance on the analysis and use of routine health information systems: eye and ear care module.

Dry Eye Awareness Month 2025

1 July 2025 -31 July 2025
Nearly 16 million Americans have dry eye, which in severe cases, may cause serious vision problems. Prevent Blindness will provide information on the condition, including symptoms, risk factors, treatment option and more.

10 daily habits damaging your eyesight and changes you can make to remedy against them

15 March 2023
Following World Glaucoma Day on 12 March this year, it is vital that the longevity of our vision is always a priority. However, many of our daily habits contribute to the onset of glaucoma and vision loss.

MOSUK Annual Meeting 2026

25 February 2026
Medical Ophthalmological Society's 27th Annual Meeting

Congenital and paediatric cataract: Advances in diagnosis and management

4 December 2025 | | EYE - Paediatrics, EYE - Cataract
Congenital and paediatric cataracts are relatively rare, although prevalence varies significantly between countries, influenced by factors such as nutrition, immunisation policy and population genetics [1]. In the UK, around 3–4 of every 10,000 babies are born with cataracts. It’s a...

Crystalline keratopathy in monoclonal gammopathy of undetermined significance

2 April 2025 | | EYE - Cornea
Monoclonal gammopathies encompass a group of plasma cell disorders characterised by the excessive production of abnormal monoclonal immunoglobulins in the bloodstream [1]. This category includes multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), amyloidosis and other lymphoproliferative disorders. Monoclonal gammopathy...

Randomisation, confounding & observational methods in ophthalmic epidemiology

1 June 2022 | | EYE - General
Randomisation and confounding Understanding the relationship between an exposure and an outcome of interest is the central challenge in ophthalmic epidemiology. The exposure may be aetiological, taking the form of a putative risk biological factor, or therapeutic, in the form...

Health information should be accessible for blind and partially sighted patients, urges RNIB

17 May 2023 | RNIB, NHS, accessibility
Blind and partially sighted people’s health is being put at risk because they are being denied their right to receive vital patient information in a format they can read.

Low Vision Questionnaire

5 February 2024 | survey, CVI, ECLOs, vision impairment, Quality Improvement, Questionnaire, CPD
Participation in this survey is greatly appreciated and will help eyecare practitioners to provide the support patients with vision loss deserve.

Lessons from an unusual case of syphilis

3 August 2023 | | EYE - Vitreo-Retinal
The rise of syphilis transmission rates over the past two decades has been one of public health’s great puzzles. In the UK, the situation has reached epidemic levels, with a 126% increase between 2013 and 2018 [1]. We present a...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...